Process Evaluation of OptimiseRx and PINCER

Last updated: February 19, 2021
Sponsor: University of Nottingham
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT04766619
17099
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This study aims to evaluate two interventions designed to make medication prescribing safer, OptimiseRx and PINCER, which are being used in general practices across England. The findings from the evaluation will be used to generate recommendations as to how these interventions can be used sustainably in the long-term.

Eligibility Criteria

Inclusion

Inclusion Criteria: Staff and stakeholders

  • Able to give written informed consent
  • 18 years of age or over (no maximum age limit)
  • Staff members working in/for a practice or a CCG or the software developer which hasreceived the intervention/s and have direct contact with it/them
  • Staff from relevant AHSNs, NHS England, the University of Nottingham or PRIMIS andother relevant staff who have had involvement in the PINCER rollout
  • Staff who have either had direct contact with, have an understanding of and/or are ina position to influence wider adoption of the PINCER and OptimseRx interventions (e.g.contracting, IT systems engineer, commissioner, etc.) Patients
  • Able to give written informed consent
  • 18 years of age or over (no maximum age limit)
  • Patients registered with a general practice who have attended a consultation (or otherrelated activity) for the PINCER intervention, or selected by their clinical careteam, or attached to a patient group within a CCG or practice or those identified viasocial media who are living with a long-term health condition and/or who requireregular blood tests to monitor their medication and have had a medication reviewwithin the past six months Members of the public and patient representatives
  • Able to give written informed consent
  • 18 years of age or over (no maximum age limit)
  • Those who have either had direct contact with the PINCER intervention or have anunderstanding of the related medicines management issues in primary care

Exclusion

Exclusion Criteria: Staff and stakeholders

  • Unable to give written informed consent
  • Under 18 years of age Patients
  • Unable to give written informed consent
  • Under 18 years of age
  • Those considered by their healthcare professional to be inappropriate to recruit dueto psycho-social reasons or significant health reasons, e.g. terminalillness/diagnosis. Members of the public and patient representatives
  • Unable to give written informed consent
  • Under 18 years of age

Study Design

Total Participants: 390
Study Start date:
February 16, 2018
Estimated Completion Date:
February 28, 2023

Study Description

This study has been designed to evaluate and gain an understanding of the 'real world' implementation, fidelity and medium and longer-term embedding and sustainability of two prescribing safety interventions: the computerised decision support (CDS) tool - Optimize Rx, and PINCER (pharmacist-led information technology intervention for reducing clinically important errors in medication management). The longitudinal process evaluation will involve observations, interviews, focus groups and questionnaires. The consolidated learning exercise, which aims to inform long-term, sustainable intervention use will involve a documentary analysis, interviews, focus groups, development workshops and a synthesis of the evaluation results.

Connect with a study center

  • University of Edinburgh

    Edinburgh,
    United Kingdom

    Active - Recruiting

  • University of Manchester

    Manchester, M13 9PT
    United Kingdom

    Completed

  • University of Nottingham

    Nottingham, NG7 2RD
    United Kingdom

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.